Letters sent to healthcare professionals in December 2016

A summary of letters sent to relevant healthcare professionals in December 2016.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 19 January 2017

• Therapeutic area: Neurology, Paediatrics and neonatology

In December 2016, the following letters were sent to relevant healthcare professionals to inform them of updated safety information for:

• levetiracetam (Keppra) 100 mg/mL: risk of medication errors
• Ammonaps (sodium phenylbutyrate): only for use when there is no alternative treatment

Article citation: Drug Safety Update volume 10 issue 6, January 2017: 5.

Published 19 January 2017